FDA Cracks Down On Stem-Cell Clinics Selling Unapproved Treatments – NPR
NPR |
FDA Cracks Down On Stem–Cell Clinics Selling Unapproved Treatments
NPR The Food and Drug Administration is cracking down on “unscrupulous” clinics selling unproven and potentially dangerous treatments involving stem cells. Hundreds of clinics around the country have started selling stem cell therapies that supposedly use … FDA Cracks Down on ‘Unscrupulous’ Stem Cell ClinicsNew York Times FDA cracks down on stem–cell clinics, including one using smallpox vaccine in cancer patientsWashington Post FDA Cracks Down on Stem Cell Clinics But Patients Are Still at RiskTIME CBS News –FDA.gov –FDA.gov –FDA.gov all 128 news articles » |
Madison.com |
Why bluebird bio Inc and Juno Therapeutics Inc Shot Higher Today
Madison.com Kite, Juno, and Bluebird are all developing chimeric antigen receptor (CAR) and the related engineered T–cell receptor (TCR) technologies, which make genetic changes to patient’s immune T cells, training them to attack cancer cells. Kite is … |
STAT |
Gilead’s Plan? Cash In on CAR–T
Motley Fool The Swiss biopharma Goliath Novartis is the only other drug developer to have a CAR–T that’s pending approval from the FDA. In Kite Pharma’s case, it’s awaiting an FDA decision on axi-cel, a CAR–T that’s under priority review for use in patients with B … Gilead just handed a revolutionary kind of cancer treatment a $12 billon endorsementBusiness Insider Gilead agrees to buy Kite Pharma, leaping into CAR–T cancer therapySTAT The Promising New Cancer Treatment Behind Gilead’s $11 Billion DealFox Business Barron’s –Reuters –Markets Insider –Zacks Investment Research all 244 news articles » |